139 related articles for article (PubMed ID: 12695540)
1. Potent inhibition of human telomerase by nitrostyrene derivatives.
Kim JH; Kim JH; Lee GE; Lee JE; Chung IK
Mol Pharmacol; 2003 May; 63(5):1117-24. PubMed ID: 12695540
[TBL] [Abstract][Full Text] [Related]
2. Identification of a quinoxaline derivative that is a potent telomerase inhibitor leading to cellular senescence of human cancer cells.
Kim JH; Kim JH; Lee GE; Kim SW; Chung IK
Biochem J; 2003 Jul; 373(Pt 2):523-9. PubMed ID: 12689331
[TBL] [Abstract][Full Text] [Related]
3. Isothiazolone derivatives selectively inhibit telomerase from human and rat cancer cells in vitro.
Hayakawa N; Nozawa K; Ogawa A; Kato N; Yoshida K; Akamatsu Ki; Tsuchiya M; Nagasaka A; Yoshida S
Biochemistry; 1999 Aug; 38(35):11501-7. PubMed ID: 10471302
[TBL] [Abstract][Full Text] [Related]
4. A novel platinum compound inhibits telomerase activity in vitro and reduces telomere length in a human hepatoma cell line.
Furuta M; Nozawa K; Takemura M; Izuta S; Murate T; Tsuchiya M; Yoshida K; Taka N; Nimura Y; Yoshida S
Int J Cancer; 2003 May; 104(6):709-15. PubMed ID: 12640677
[TBL] [Abstract][Full Text] [Related]
5. Potent inhibition of human telomerase by helenalin.
Huang PR; Yeh YM; Wang TC
Cancer Lett; 2005 Sep; 227(2):169-74. PubMed ID: 16112419
[TBL] [Abstract][Full Text] [Related]
6. A highly selective telomerase inhibitor limiting human cancer cell proliferation.
Damm K; Hemmann U; Garin-Chesa P; Hauel N; Kauffmann I; Priepke H; Niestroj C; Daiber C; Enenkel B; Guilliard B; Lauritsch I; Müller E; Pascolo E; Sauter G; Pantic M; Martens UM; Wenz C; Lingner J; Kraut N; Rettig WJ; Schnapp A
EMBO J; 2001 Dec; 20(24):6958-68. PubMed ID: 11742973
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of human telomerase inhibition by BIBR1532, a synthetic, non-nucleosidic drug candidate.
Pascolo E; Wenz C; Lingner J; Hauel N; Priepke H; Kauffmann I; Garin-Chesa P; Rettig WJ; Damm K; Schnapp A
J Biol Chem; 2002 May; 277(18):15566-72. PubMed ID: 11854300
[TBL] [Abstract][Full Text] [Related]
8. Telomerase inhibition and cancer: might platinum based drugs have a future as anti-telomerase pharmacological approach?
Colangelo D; Osella D
Curr Med Chem; 2005; 12(26):3091-102. PubMed ID: 16375703
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human telomerase by rubromycins: implication of spiroketal system of the compounds as an active moiety.
Ueno T; Takahashi H; Oda M; Mizunuma M; Yokoyama A; Goto Y; Mizushina Y; Sakaguchi K; Hayashi H
Biochemistry; 2000 May; 39(20):5995-6002. PubMed ID: 10821671
[TBL] [Abstract][Full Text] [Related]
10. Telomerase inhibition as cancer therapy.
Saretzki G
Cancer Lett; 2003 May; 194(2):209-19. PubMed ID: 12757979
[TBL] [Abstract][Full Text] [Related]
11. Telomerase inhibitors identified by a forward chemical genetics approach using a yeast strain with shortened telomere length.
Nakai R; Ishida H; Asai A; Ogawa H; Yamamoto Y; Kawasaki H; Akinaga S; Mizukami T; Yamashita Y
Chem Biol; 2006 Feb; 13(2):183-90. PubMed ID: 16492566
[TBL] [Abstract][Full Text] [Related]
12. Nucleic acid-binding ligands identify new mechanisms to inhibit telomerase.
Dominick PK; Keppler BR; Legassie JD; Moon IK; Jarstfer MB
Bioorg Med Chem Lett; 2004 Jul; 14(13):3467-71. PubMed ID: 15177454
[TBL] [Abstract][Full Text] [Related]
13. Stilbene Compounds Inhibit Tumor Growth by the Induction of Cellular Senescence and the Inhibition of Telomerase Activity.
Lee YH; Chen YY; Yeh YL; Wang YJ; Chen RJ
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31159515
[No Abstract] [Full Text] [Related]
14. Oligonucleotide N3'-->P5' phosphoramidates as efficient telomerase inhibitors.
Herbert BS; Pongracz K; Shay JW; Gryaznov SM
Oncogene; 2002 Jan; 21(4):638-42. PubMed ID: 11850790
[TBL] [Abstract][Full Text] [Related]
15. Human telomerase inhibition by regioisomeric disubstituted amidoanthracene-9,10-diones.
Perry PJ; Reszka AP; Wood AA; Read MA; Gowan SM; Dosanjh HS; Trent JO; Jenkins TC; Kelland LR; Neidle S
J Med Chem; 1998 Nov; 41(24):4873-84. PubMed ID: 9822556
[TBL] [Abstract][Full Text] [Related]
16. Telomerase inhibition, telomere shortening, cell growth suppression and induction of apoptosis by telomestatin in childhood neuroblastoma cells.
Binz N; Shalaby T; Rivera P; Shin-ya K; Grotzer MA
Eur J Cancer; 2005 Dec; 41(18):2873-81. PubMed ID: 16253503
[TBL] [Abstract][Full Text] [Related]
17. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
Kelland LR
Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
[TBL] [Abstract][Full Text] [Related]
18. Telomere length maintenance in aging and carcinogenesis.
Aragona M; Maisano R; Panetta S; Giudice A; Morelli M; La Torre I; La Torre F
Int J Oncol; 2000 Nov; 17(5):981-9. PubMed ID: 11029502
[TBL] [Abstract][Full Text] [Related]
19. 3'-Azido-2',3'-dideoxynucleoside 5'-triphosphates inhibit telomerase activity in vitro, and the corresponding nucleosides cause telomere shortening in human HL60 cells.
Liu X; Takahashi H; Harada Y; Ogawara T; Ogimura Y; Mizushina Y; Saneyoshi M; Yamaguchi T
Nucleic Acids Res; 2007; 35(21):7140-9. PubMed ID: 17942424
[TBL] [Abstract][Full Text] [Related]
20. 1,4- and 2,6-disubstituted amidoanthracene-9,10-dione derivatives as inhibitors of human telomerase.
Perry PJ; Gowan SM; Reszka AP; Polucci P; Jenkins TC; Kelland LR; Neidle S
J Med Chem; 1998 Aug; 41(17):3253-60. PubMed ID: 9703471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
